Generic Name and Formulations:
Dexamethasone 0.1%; oph susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for MAXIDEX:
Adults and Children:
Instill 1–2 drops in the affected eye(s). Severe: may administer hourly, then taper as condition improves. Mild: may administer up to 4–6 times daily.
Acute, untreated bacterial, fungal, mycobacterial, epithelial herpes simplex, or viral (except herpes zoster) infections of the eye.
Corneal or scleral thinning. Glaucoma. Monitor for secondary infections and intraocular pressure if used for ≥10 days. Avoid abrupt cessation. Pregnancy. Nursing mothers.
Local irritation, ocular discomfort, increased intraocular pressure, cataracts, corneal perforations, optic nerve damage; may mask or exacerbate infections.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation